ARTICLE | Clinical News
Betmiga mirabegron regulatory update
September 15, 2014 7:00 AM UTC
Germany's Institute for Quality and Efficiency in Healthcare (IQWiG) said in a preliminary benefit assessment that Betmiga mirabegron from Astellas provides no additional benefit over appropriate comp...